Global Artesunate Medicines Market Research Report 2023
Artesunate (AS) is a medication used to treat malaria. The intravenous form is preferred to quinidine for severe malaria. Often it is used as part of combination therapy. It is not used for the prevention of malaria.
According to QYResearch’s new survey, global Artesunate Medicines market is projected to reach US$ 277.7 million in 2029, increasing from US$ 168 million in 2022, with the CAGR of 7.2% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Artesunate Medicines market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Artesunate Medicines market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
According to QYResearch’s new survey, global Artesunate Medicines market is projected to reach US$ 277.7 million in 2029, increasing from US$ 168 million in 2022, with the CAGR of 7.2% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Artesunate Medicines market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Artesunate Medicines market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
- Fosun Pharma (Guilin)
- Ipca Laboratories
- Sanofi Aventis
- Ajanta Pharma
- Shin Poong
- Cipla
- Acino
- MCW Healthcare
- Monoaromatic Artesunate
- Compound Artesunate
- Hospital
- Clinic
- Other
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Artesunate Medicines Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Monoaromatic Artesunate
1.2.3 Compound Artesunate
1.3 Market by Application
1.3.1 Global Artesunate Medicines Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Artesunate Medicines Market Perspective (2018-2029)
2.2 Artesunate Medicines Growth Trends by Region
2.2.1 Global Artesunate Medicines Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Artesunate Medicines Historic Market Size by Region (2018-2023)
2.2.3 Artesunate Medicines Forecasted Market Size by Region (2024-2029)
2.3 Artesunate Medicines Market Dynamics
2.3.1 Artesunate Medicines Industry Trends
2.3.2 Artesunate Medicines Market Drivers
2.3.3 Artesunate Medicines Market Challenges
2.3.4 Artesunate Medicines Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Artesunate Medicines Players by Revenue
3.1.1 Global Top Artesunate Medicines Players by Revenue (2018-2023)
3.1.2 Global Artesunate Medicines Revenue Market Share by Players (2018-2023)
3.2 Global Artesunate Medicines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Artesunate Medicines Revenue
3.4 Global Artesunate Medicines Market Concentration Ratio
3.4.1 Global Artesunate Medicines Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Artesunate Medicines Revenue in 2022
3.5 Artesunate Medicines Key Players Head office and Area Served
3.6 Key Players Artesunate Medicines Product Solution and Service
3.7 Date of Enter into Artesunate Medicines Market
3.8 Mergers & Acquisitions, Expansion Plans
4 ARTESUNATE MEDICINES BREAKDOWN DATA BY TYPE
4.1 Global Artesunate Medicines Historic Market Size by Type (2018-2023)
4.2 Global Artesunate Medicines Forecasted Market Size by Type (2024-2029)
5 ARTESUNATE MEDICINES BREAKDOWN DATA BY APPLICATION
5.1 Global Artesunate Medicines Historic Market Size by Application (2018-2023)
5.2 Global Artesunate Medicines Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Artesunate Medicines Market Size (2018-2029)
6.2 North America Artesunate Medicines Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Artesunate Medicines Market Size by Country (2018-2023)
6.4 North America Artesunate Medicines Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 EUROPE
7.1 Europe Artesunate Medicines Market Size (2018-2029)
7.2 Europe Artesunate Medicines Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Artesunate Medicines Market Size by Country (2018-2023)
7.4 Europe Artesunate Medicines Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 ASIA-PACIFIC
8.1 Asia-Pacific Artesunate Medicines Market Size (2018-2029)
8.2 Asia-Pacific Artesunate Medicines Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Artesunate Medicines Market Size by Region (2018-2023)
8.4 Asia-Pacific Artesunate Medicines Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 LATIN AMERICA
9.1 Latin America Artesunate Medicines Market Size (2018-2029)
9.2 Latin America Artesunate Medicines Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Artesunate Medicines Market Size by Country (2018-2023)
9.4 Latin America Artesunate Medicines Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Artesunate Medicines Market Size (2018-2029)
10.2 Middle East & Africa Artesunate Medicines Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Artesunate Medicines Market Size by Country (2018-2023)
10.4 Middle East & Africa Artesunate Medicines Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 KEY PLAYERS PROFILES
11.1 Fosun Pharma (Guilin)
11.1.1 Fosun Pharma (Guilin) Company Detail
11.1.2 Fosun Pharma (Guilin) Business Overview
11.1.3 Fosun Pharma (Guilin) Artesunate Medicines Introduction
11.1.4 Fosun Pharma (Guilin) Revenue in Artesunate Medicines Business (2018-2023)
11.1.5 Fosun Pharma (Guilin) Recent Development
11.2 Ipca Laboratories
11.2.1 Ipca Laboratories Company Detail
11.2.2 Ipca Laboratories Business Overview
11.2.3 Ipca Laboratories Artesunate Medicines Introduction
11.2.4 Ipca Laboratories Revenue in Artesunate Medicines Business (2018-2023)
11.2.5 Ipca Laboratories Recent Development
11.3 Sanofi Aventis
11.3.1 Sanofi Aventis Company Detail
11.3.2 Sanofi Aventis Business Overview
11.3.3 Sanofi Aventis Artesunate Medicines Introduction
11.3.4 Sanofi Aventis Revenue in Artesunate Medicines Business (2018-2023)
11.3.5 Sanofi Aventis Recent Development
11.4 Ajanta Pharma
11.4.1 Ajanta Pharma Company Detail
11.4.2 Ajanta Pharma Business Overview
11.4.3 Ajanta Pharma Artesunate Medicines Introduction
11.4.4 Ajanta Pharma Revenue in Artesunate Medicines Business (2018-2023)
11.4.5 Ajanta Pharma Recent Development
11.5 Shin Poong
11.5.1 Shin Poong Company Detail
11.5.2 Shin Poong Business Overview
11.5.3 Shin Poong Artesunate Medicines Introduction
11.5.4 Shin Poong Revenue in Artesunate Medicines Business (2018-2023)
11.5.5 Shin Poong Recent Development
11.6 Cipla
11.6.1 Cipla Company Detail
11.6.2 Cipla Business Overview
11.6.3 Cipla Artesunate Medicines Introduction
11.6.4 Cipla Revenue in Artesunate Medicines Business (2018-2023)
11.6.5 Cipla Recent Development
11.7 Acino
11.7.1 Acino Company Detail
11.7.2 Acino Business Overview
11.7.3 Acino Artesunate Medicines Introduction
11.7.4 Acino Revenue in Artesunate Medicines Business (2018-2023)
11.7.5 Acino Recent Development
11.8 MCW Healthcare
11.8.1 MCW Healthcare Company Detail
11.8.2 MCW Healthcare Business Overview
11.8.3 MCW Healthcare Artesunate Medicines Introduction
11.8.4 MCW Healthcare Revenue in Artesunate Medicines Business (2018-2023)
11.8.5 MCW Healthcare Recent Development
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Artesunate Medicines Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Monoaromatic Artesunate
1.2.3 Compound Artesunate
1.3 Market by Application
1.3.1 Global Artesunate Medicines Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Artesunate Medicines Market Perspective (2018-2029)
2.2 Artesunate Medicines Growth Trends by Region
2.2.1 Global Artesunate Medicines Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Artesunate Medicines Historic Market Size by Region (2018-2023)
2.2.3 Artesunate Medicines Forecasted Market Size by Region (2024-2029)
2.3 Artesunate Medicines Market Dynamics
2.3.1 Artesunate Medicines Industry Trends
2.3.2 Artesunate Medicines Market Drivers
2.3.3 Artesunate Medicines Market Challenges
2.3.4 Artesunate Medicines Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Artesunate Medicines Players by Revenue
3.1.1 Global Top Artesunate Medicines Players by Revenue (2018-2023)
3.1.2 Global Artesunate Medicines Revenue Market Share by Players (2018-2023)
3.2 Global Artesunate Medicines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Artesunate Medicines Revenue
3.4 Global Artesunate Medicines Market Concentration Ratio
3.4.1 Global Artesunate Medicines Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Artesunate Medicines Revenue in 2022
3.5 Artesunate Medicines Key Players Head office and Area Served
3.6 Key Players Artesunate Medicines Product Solution and Service
3.7 Date of Enter into Artesunate Medicines Market
3.8 Mergers & Acquisitions, Expansion Plans
4 ARTESUNATE MEDICINES BREAKDOWN DATA BY TYPE
4.1 Global Artesunate Medicines Historic Market Size by Type (2018-2023)
4.2 Global Artesunate Medicines Forecasted Market Size by Type (2024-2029)
5 ARTESUNATE MEDICINES BREAKDOWN DATA BY APPLICATION
5.1 Global Artesunate Medicines Historic Market Size by Application (2018-2023)
5.2 Global Artesunate Medicines Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Artesunate Medicines Market Size (2018-2029)
6.2 North America Artesunate Medicines Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Artesunate Medicines Market Size by Country (2018-2023)
6.4 North America Artesunate Medicines Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 EUROPE
7.1 Europe Artesunate Medicines Market Size (2018-2029)
7.2 Europe Artesunate Medicines Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Artesunate Medicines Market Size by Country (2018-2023)
7.4 Europe Artesunate Medicines Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 ASIA-PACIFIC
8.1 Asia-Pacific Artesunate Medicines Market Size (2018-2029)
8.2 Asia-Pacific Artesunate Medicines Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Artesunate Medicines Market Size by Region (2018-2023)
8.4 Asia-Pacific Artesunate Medicines Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 LATIN AMERICA
9.1 Latin America Artesunate Medicines Market Size (2018-2029)
9.2 Latin America Artesunate Medicines Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Artesunate Medicines Market Size by Country (2018-2023)
9.4 Latin America Artesunate Medicines Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Artesunate Medicines Market Size (2018-2029)
10.2 Middle East & Africa Artesunate Medicines Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Artesunate Medicines Market Size by Country (2018-2023)
10.4 Middle East & Africa Artesunate Medicines Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 KEY PLAYERS PROFILES
11.1 Fosun Pharma (Guilin)
11.1.1 Fosun Pharma (Guilin) Company Detail
11.1.2 Fosun Pharma (Guilin) Business Overview
11.1.3 Fosun Pharma (Guilin) Artesunate Medicines Introduction
11.1.4 Fosun Pharma (Guilin) Revenue in Artesunate Medicines Business (2018-2023)
11.1.5 Fosun Pharma (Guilin) Recent Development
11.2 Ipca Laboratories
11.2.1 Ipca Laboratories Company Detail
11.2.2 Ipca Laboratories Business Overview
11.2.3 Ipca Laboratories Artesunate Medicines Introduction
11.2.4 Ipca Laboratories Revenue in Artesunate Medicines Business (2018-2023)
11.2.5 Ipca Laboratories Recent Development
11.3 Sanofi Aventis
11.3.1 Sanofi Aventis Company Detail
11.3.2 Sanofi Aventis Business Overview
11.3.3 Sanofi Aventis Artesunate Medicines Introduction
11.3.4 Sanofi Aventis Revenue in Artesunate Medicines Business (2018-2023)
11.3.5 Sanofi Aventis Recent Development
11.4 Ajanta Pharma
11.4.1 Ajanta Pharma Company Detail
11.4.2 Ajanta Pharma Business Overview
11.4.3 Ajanta Pharma Artesunate Medicines Introduction
11.4.4 Ajanta Pharma Revenue in Artesunate Medicines Business (2018-2023)
11.4.5 Ajanta Pharma Recent Development
11.5 Shin Poong
11.5.1 Shin Poong Company Detail
11.5.2 Shin Poong Business Overview
11.5.3 Shin Poong Artesunate Medicines Introduction
11.5.4 Shin Poong Revenue in Artesunate Medicines Business (2018-2023)
11.5.5 Shin Poong Recent Development
11.6 Cipla
11.6.1 Cipla Company Detail
11.6.2 Cipla Business Overview
11.6.3 Cipla Artesunate Medicines Introduction
11.6.4 Cipla Revenue in Artesunate Medicines Business (2018-2023)
11.6.5 Cipla Recent Development
11.7 Acino
11.7.1 Acino Company Detail
11.7.2 Acino Business Overview
11.7.3 Acino Artesunate Medicines Introduction
11.7.4 Acino Revenue in Artesunate Medicines Business (2018-2023)
11.7.5 Acino Recent Development
11.8 MCW Healthcare
11.8.1 MCW Healthcare Company Detail
11.8.2 MCW Healthcare Business Overview
11.8.3 MCW Healthcare Artesunate Medicines Introduction
11.8.4 MCW Healthcare Revenue in Artesunate Medicines Business (2018-2023)
11.8.5 MCW Healthcare Recent Development
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
LIST OF TABLES
Table 1. Global Artesunate Medicines Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Monoaromatic Artesunate
Table 3. Key Players of Compound Artesunate
Table 4. Global Artesunate Medicines Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global Artesunate Medicines Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Artesunate Medicines Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Artesunate Medicines Market Share by Region (2018-2023)
Table 8. Global Artesunate Medicines Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Artesunate Medicines Market Share by Region (2024-2029)
Table 10. Artesunate Medicines Market Trends
Table 11. Artesunate Medicines Market Drivers
Table 12. Artesunate Medicines Market Challenges
Table 13. Artesunate Medicines Market Restraints
Table 14. Global Artesunate Medicines Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Artesunate Medicines Market Share by Players (2018-2023)
Table 16. Global Top Artesunate Medicines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Artesunate Medicines as of 2022)
Table 17. Ranking of Global Top Artesunate Medicines Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Artesunate Medicines Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Artesunate Medicines Product Solution and Service
Table 21. Date of Enter into Artesunate Medicines Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Artesunate Medicines Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Artesunate Medicines Revenue Market Share by Type (2018-2023)
Table 25. Global Artesunate Medicines Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Artesunate Medicines Revenue Market Share by Type (2024-2029)
Table 27. Global Artesunate Medicines Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Artesunate Medicines Revenue Market Share by Application (2018-2023)
Table 29. Global Artesunate Medicines Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Artesunate Medicines Revenue Market Share by Application (2024-2029)
Table 31. North America Artesunate Medicines Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America Artesunate Medicines Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Artesunate Medicines Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe Artesunate Medicines Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe Artesunate Medicines Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Artesunate Medicines Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific Artesunate Medicines Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific Artesunate Medicines Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Artesunate Medicines Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America Artesunate Medicines Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America Artesunate Medicines Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Artesunate Medicines Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa Artesunate Medicines Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa Artesunate Medicines Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Artesunate Medicines Market Size by Country (2024-2029) & (US$ Million)
Table 46. Fosun Pharma (Guilin) Company Detail
Table 47. Fosun Pharma (Guilin) Business Overview
Table 48. Fosun Pharma (Guilin) Artesunate Medicines Product
Table 49. Fosun Pharma (Guilin) Revenue in Artesunate Medicines Business (2018-2023) & (US$ Million)
Table 50. Fosun Pharma (Guilin) Recent Development
Table 51. Ipca Laboratories Company Detail
Table 52. Ipca Laboratories Business Overview
Table 53. Ipca Laboratories Artesunate Medicines Product
Table 54. Ipca Laboratories Revenue in Artesunate Medicines Business (2018-2023) & (US$ Million)
Table 55. Ipca Laboratories Recent Development
Table 56. Sanofi Aventis Company Detail
Table 57. Sanofi Aventis Business Overview
Table 58. Sanofi Aventis Artesunate Medicines Product
Table 59. Sanofi Aventis Revenue in Artesunate Medicines Business (2018-2023) & (US$ Million)
Table 60. Sanofi Aventis Recent Development
Table 61. Ajanta Pharma Company Detail
Table 62. Ajanta Pharma Business Overview
Table 63. Ajanta Pharma Artesunate Medicines Product
Table 64. Ajanta Pharma Revenue in Artesunate Medicines Business (2018-2023) & (US$ Million)
Table 65. Ajanta Pharma Recent Development
Table 66. Shin Poong Company Detail
Table 67. Shin Poong Business Overview
Table 68. Shin Poong Artesunate Medicines Product
Table 69. Shin Poong Revenue in Artesunate Medicines Business (2018-2023) & (US$ Million)
Table 70. Shin Poong Recent Development
Table 71. Cipla Company Detail
Table 72. Cipla Business Overview
Table 73. Cipla Artesunate Medicines Product
Table 74. Cipla Revenue in Artesunate Medicines Business (2018-2023) & (US$ Million)
Table 75. Cipla Recent Development
Table 76. Acino Company Detail
Table 77. Acino Business Overview
Table 78. Acino Artesunate Medicines Product
Table 79. Acino Revenue in Artesunate Medicines Business (2018-2023) & (US$ Million)
Table 80. Acino Recent Development
Table 81. MCW Healthcare Company Detail
Table 82. MCW Healthcare Business Overview
Table 83. MCW Healthcare Artesunate Medicines Product
Table 84. MCW Healthcare Revenue in Artesunate Medicines Business (2018-2023) & (US$ Million)
Table 85. MCW Healthcare Recent Development
Table 86. Research Programs/Design for This Report
Table 87. Key Data Information from Secondary Sources
Table 88. Key Data Information from Primary Sources
Table 1. Global Artesunate Medicines Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Monoaromatic Artesunate
Table 3. Key Players of Compound Artesunate
Table 4. Global Artesunate Medicines Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global Artesunate Medicines Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Artesunate Medicines Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Artesunate Medicines Market Share by Region (2018-2023)
Table 8. Global Artesunate Medicines Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Artesunate Medicines Market Share by Region (2024-2029)
Table 10. Artesunate Medicines Market Trends
Table 11. Artesunate Medicines Market Drivers
Table 12. Artesunate Medicines Market Challenges
Table 13. Artesunate Medicines Market Restraints
Table 14. Global Artesunate Medicines Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Artesunate Medicines Market Share by Players (2018-2023)
Table 16. Global Top Artesunate Medicines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Artesunate Medicines as of 2022)
Table 17. Ranking of Global Top Artesunate Medicines Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Artesunate Medicines Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Artesunate Medicines Product Solution and Service
Table 21. Date of Enter into Artesunate Medicines Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Artesunate Medicines Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Artesunate Medicines Revenue Market Share by Type (2018-2023)
Table 25. Global Artesunate Medicines Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Artesunate Medicines Revenue Market Share by Type (2024-2029)
Table 27. Global Artesunate Medicines Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Artesunate Medicines Revenue Market Share by Application (2018-2023)
Table 29. Global Artesunate Medicines Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Artesunate Medicines Revenue Market Share by Application (2024-2029)
Table 31. North America Artesunate Medicines Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America Artesunate Medicines Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Artesunate Medicines Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe Artesunate Medicines Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe Artesunate Medicines Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Artesunate Medicines Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific Artesunate Medicines Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific Artesunate Medicines Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Artesunate Medicines Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America Artesunate Medicines Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America Artesunate Medicines Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Artesunate Medicines Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa Artesunate Medicines Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa Artesunate Medicines Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Artesunate Medicines Market Size by Country (2024-2029) & (US$ Million)
Table 46. Fosun Pharma (Guilin) Company Detail
Table 47. Fosun Pharma (Guilin) Business Overview
Table 48. Fosun Pharma (Guilin) Artesunate Medicines Product
Table 49. Fosun Pharma (Guilin) Revenue in Artesunate Medicines Business (2018-2023) & (US$ Million)
Table 50. Fosun Pharma (Guilin) Recent Development
Table 51. Ipca Laboratories Company Detail
Table 52. Ipca Laboratories Business Overview
Table 53. Ipca Laboratories Artesunate Medicines Product
Table 54. Ipca Laboratories Revenue in Artesunate Medicines Business (2018-2023) & (US$ Million)
Table 55. Ipca Laboratories Recent Development
Table 56. Sanofi Aventis Company Detail
Table 57. Sanofi Aventis Business Overview
Table 58. Sanofi Aventis Artesunate Medicines Product
Table 59. Sanofi Aventis Revenue in Artesunate Medicines Business (2018-2023) & (US$ Million)
Table 60. Sanofi Aventis Recent Development
Table 61. Ajanta Pharma Company Detail
Table 62. Ajanta Pharma Business Overview
Table 63. Ajanta Pharma Artesunate Medicines Product
Table 64. Ajanta Pharma Revenue in Artesunate Medicines Business (2018-2023) & (US$ Million)
Table 65. Ajanta Pharma Recent Development
Table 66. Shin Poong Company Detail
Table 67. Shin Poong Business Overview
Table 68. Shin Poong Artesunate Medicines Product
Table 69. Shin Poong Revenue in Artesunate Medicines Business (2018-2023) & (US$ Million)
Table 70. Shin Poong Recent Development
Table 71. Cipla Company Detail
Table 72. Cipla Business Overview
Table 73. Cipla Artesunate Medicines Product
Table 74. Cipla Revenue in Artesunate Medicines Business (2018-2023) & (US$ Million)
Table 75. Cipla Recent Development
Table 76. Acino Company Detail
Table 77. Acino Business Overview
Table 78. Acino Artesunate Medicines Product
Table 79. Acino Revenue in Artesunate Medicines Business (2018-2023) & (US$ Million)
Table 80. Acino Recent Development
Table 81. MCW Healthcare Company Detail
Table 82. MCW Healthcare Business Overview
Table 83. MCW Healthcare Artesunate Medicines Product
Table 84. MCW Healthcare Revenue in Artesunate Medicines Business (2018-2023) & (US$ Million)
Table 85. MCW Healthcare Recent Development
Table 86. Research Programs/Design for This Report
Table 87. Key Data Information from Secondary Sources
Table 88. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Artesunate Medicines Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Artesunate Medicines Market Share by Type: 2022 VS 2029
Figure 3. Monoaromatic Artesunate Features
Figure 4. Compound Artesunate Features
Figure 5. Global Artesunate Medicines Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 6. Global Artesunate Medicines Market Share by Application: 2022 VS 2029
Figure 7. Hospital Case Studies
Figure 8. Clinic Case Studies
Figure 9. Other Case Studies
Figure 10. Artesunate Medicines Report Years Considered
Figure 11. Global Artesunate Medicines Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global Artesunate Medicines Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Artesunate Medicines Market Share by Region: 2022 VS 2029
Figure 14. Global Artesunate Medicines Market Share by Players in 2022
Figure 15. Global Top Artesunate Medicines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Artesunate Medicines as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Artesunate Medicines Revenue in 2022
Figure 17. North America Artesunate Medicines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America Artesunate Medicines Market Share by Country (2018-2029)
Figure 19. United States Artesunate Medicines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. Canada Artesunate Medicines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Europe Artesunate Medicines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Artesunate Medicines Market Share by Country (2018-2029)
Figure 23. Germany Artesunate Medicines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. France Artesunate Medicines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. U.K. Artesunate Medicines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Italy Artesunate Medicines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Russia Artesunate Medicines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Nordic Countries Artesunate Medicines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Asia-Pacific Artesunate Medicines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Artesunate Medicines Market Share by Region (2018-2029)
Figure 31. China Artesunate Medicines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Japan Artesunate Medicines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. South Korea Artesunate Medicines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Southeast Asia Artesunate Medicines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. India Artesunate Medicines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Australia Artesunate Medicines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Latin America Artesunate Medicines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Artesunate Medicines Market Share by Country (2018-2029)
Figure 39. Mexico Artesunate Medicines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Brazil Artesunate Medicines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Middle East & Africa Artesunate Medicines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Artesunate Medicines Market Share by Country (2018-2029)
Figure 43. Turkey Artesunate Medicines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Saudi Arabia Artesunate Medicines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Fosun Pharma (Guilin) Revenue Growth Rate in Artesunate Medicines Business (2018-2023)
Figure 46. Ipca Laboratories Revenue Growth Rate in Artesunate Medicines Business (2018-2023)
Figure 47. Sanofi Aventis Revenue Growth Rate in Artesunate Medicines Business (2018-2023)
Figure 48. Ajanta Pharma Revenue Growth Rate in Artesunate Medicines Business (2018-2023)
Figure 49. Shin Poong Revenue Growth Rate in Artesunate Medicines Business (2018-2023)
Figure 50. Cipla Revenue Growth Rate in Artesunate Medicines Business (2018-2023)
Figure 51. Acino Revenue Growth Rate in Artesunate Medicines Business (2018-2023)
Figure 52. MCW Healthcare Revenue Growth Rate in Artesunate Medicines Business (2018-2023)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed
Figure 1. Global Artesunate Medicines Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Artesunate Medicines Market Share by Type: 2022 VS 2029
Figure 3. Monoaromatic Artesunate Features
Figure 4. Compound Artesunate Features
Figure 5. Global Artesunate Medicines Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 6. Global Artesunate Medicines Market Share by Application: 2022 VS 2029
Figure 7. Hospital Case Studies
Figure 8. Clinic Case Studies
Figure 9. Other Case Studies
Figure 10. Artesunate Medicines Report Years Considered
Figure 11. Global Artesunate Medicines Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global Artesunate Medicines Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Artesunate Medicines Market Share by Region: 2022 VS 2029
Figure 14. Global Artesunate Medicines Market Share by Players in 2022
Figure 15. Global Top Artesunate Medicines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Artesunate Medicines as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Artesunate Medicines Revenue in 2022
Figure 17. North America Artesunate Medicines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America Artesunate Medicines Market Share by Country (2018-2029)
Figure 19. United States Artesunate Medicines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. Canada Artesunate Medicines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Europe Artesunate Medicines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Artesunate Medicines Market Share by Country (2018-2029)
Figure 23. Germany Artesunate Medicines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. France Artesunate Medicines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. U.K. Artesunate Medicines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Italy Artesunate Medicines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Russia Artesunate Medicines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Nordic Countries Artesunate Medicines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Asia-Pacific Artesunate Medicines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Artesunate Medicines Market Share by Region (2018-2029)
Figure 31. China Artesunate Medicines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Japan Artesunate Medicines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. South Korea Artesunate Medicines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Southeast Asia Artesunate Medicines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. India Artesunate Medicines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Australia Artesunate Medicines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Latin America Artesunate Medicines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Artesunate Medicines Market Share by Country (2018-2029)
Figure 39. Mexico Artesunate Medicines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Brazil Artesunate Medicines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Middle East & Africa Artesunate Medicines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Artesunate Medicines Market Share by Country (2018-2029)
Figure 43. Turkey Artesunate Medicines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Saudi Arabia Artesunate Medicines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Fosun Pharma (Guilin) Revenue Growth Rate in Artesunate Medicines Business (2018-2023)
Figure 46. Ipca Laboratories Revenue Growth Rate in Artesunate Medicines Business (2018-2023)
Figure 47. Sanofi Aventis Revenue Growth Rate in Artesunate Medicines Business (2018-2023)
Figure 48. Ajanta Pharma Revenue Growth Rate in Artesunate Medicines Business (2018-2023)
Figure 49. Shin Poong Revenue Growth Rate in Artesunate Medicines Business (2018-2023)
Figure 50. Cipla Revenue Growth Rate in Artesunate Medicines Business (2018-2023)
Figure 51. Acino Revenue Growth Rate in Artesunate Medicines Business (2018-2023)
Figure 52. MCW Healthcare Revenue Growth Rate in Artesunate Medicines Business (2018-2023)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed
